Research / NVT / Fundamental state Inspectable configuration
State dimensions Filing 0001720635-25-000018 General Corporate
Debt relative to revenue 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
71.69% · OPTIONAL · VALID
Capex intensity 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.46% · OPTIONAL · VALID
Operating cash generation 90th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
21.39% · OPTIONAL · VALID
Share-count growth 80th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.shares_outstanding
-0.03% · CORE · VALID
Revenue growth 20th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-7.89% · CORE · VALID
Inventory pressure 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
11.99% · OPTIONAL · VALID
Gross margin 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
40.22% · CORE · VALID
Operating margin 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
17.53% · CORE · VALID
R&D intensity 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.20% · OPTIONAL · VALID
SBC intensity 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.91% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 10/10 normalized Level 3 Dec 31, 2021 10/10 normalized Level 3 Mar 31, 2022 10/10 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 10/10 normalized Level 3 Mar 31, 2023 10/10 normalized Level 3 Jun 30, 2023 10/10 normalized Level 3 Sep 30, 2023 10/10 normalized Level 3 Dec 31, 2023 10/10 normalized Level 3 Mar 31, 2024 10/10 normalized Level 3 Jun 30, 2024 10/10 normalized Level 3 Sep 30, 2024 10/10 normalized Level 3 Dec 31, 2024 10/10 normalized Level 3 Mar 31, 2025 10/10 normalized Level 3 Jun 30, 2025 10/10 normalized Level 3 Sep 30, 2025 10/10 normalized Level 3 Dec 31, 2025 10/10 normalized Level 3 Mar 31, 2026 10/10 normalized Level 3 Jun 30, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 288.77%
Current 71.69%
Delta -217.08% Capex Intensity Increased
Previous 1.65%
Current 2.46%
Delta 0.81% Cash Generation Decreased
Previous 25.28%
Current 21.39%
Delta -3.89% Dilution Increased
Previous -0.66%
Current -0.03%
Delta 0.63% Growth Increased
Previous -8.94%
Current -7.89%
Delta 1.05% Inventory Pressure Decreased
Previous 46.83%
Current 11.99%
Delta -34.84% Margin Increased
Previous 39.78%
Current 40.22%
Delta 0.44% Profitability Increased
Previous 17.03%
Current 17.53%
Delta 0.50% R And D Intensity Increased
Previous 2.06%
Current 2.20%
Delta 0.14% Sbc Intensity Decreased
Previous 0.95%
Current 0.91%
Delta -0.04% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.